CA
CADL icon

Cliff Asness’s Candel Therapeutics CADL Stock Holding History

Cliff Asness’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
20,417
+2,389
+13% +$18K ﹤0.01% 3793
2026
Q1 		$88.3K Buy
+18,028
New +$98.1K ﹤0.01% 3691
2025
Q3 		– Sell
-19,261
Closed -$97.5K – 3482
2025
Q2 		$97.5K Sell
19,261
-1,757
-8% -$9.04K ﹤0.01% 3180
2025
Q1 		$119K Sell
21,018
-841
-4% -$6.87K ﹤0.01% 2985
2024
Q4 		$190K Buy
21,859
+1,823
+9% +$10.8K ﹤0.01% 2681
2024
Q3 		$139K Buy
+20,036
New +$124K ﹤0.01% 2623

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cliff Asness's CADL Position: Q2 2026 in Review

Cliff Asness increased its Candel Therapeutics (CADL) stake by 13% in Q2 2026, buying an estimated $18K and bringing the position to 20,417 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #3793.

Cliff Asness first reported a position in CADL in Q3 2024 and has held it in 6 quarters since. 137 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Cliff Asness held 20,417 shares of Candel Therapeutics worth $210K as of Q2 2026.
  • Cliff Asness bought 2,389 Candel Therapeutics shares in Q2 2026, an estimated $18K.
  • Candel Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3793 holding.
  • Cliff Asness first reported a position in Candel Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 137 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.